WO2023203501 - 2'-FUCOSYLLACTOSE AND 6'-SIALYLLACTOSE FOR MODULATING THE IMMUNE SYSTEM
National phase entry is expected:
Publication Number
WO/2023/203501
Publication Date
26.10.2023
International Application No.
PCT/IB2023/053995
International Filing Date
19.04.2023
Title **
[English]
2'-FUCOSYLLACTOSE AND 6'-SIALYLLACTOSE FOR MODULATING THE IMMUNE SYSTEM
[French]
2'-FUCOSYLLACTOSE ET 6'-SIALYLLACTOSE POUR MODULER LE SYSTÈME IMMUNITAIRE
Applicants **
HEALTH AND HAPPINESS (H&H) HONG KONG LTD
Inventors
LANE, Jonathan
WALSH, Clodagh
HICKEY, Rita
Priority Data
PCT/IB2022/053777
22.04.2022
IB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| * | |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2039 | |
| EPO | Filing, Examination, Granting | 8736 | |
| Japan | Filing, Examination, Granting | 2215 | |
| South Korea | Filing, Examination, Granting | 2200 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
20,530
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a combination of 2'-fucosyllactose and 6'-sialyllactose for stimulating and/or modulating the immune system of an individual. In particular, the present invention pertains to the use of these compounds for preventing and/or treating disorders and/or diseases associated with inflammatory reactions. A pharmaceutical and food composition is provided containing these compounds.[French]
La présente invention concerne une combinaison de 2'-fucosyllactose et de 6'-sialyllactose pour stimuler et/ou moduler le système immunitaire d'un individu. En particulier, la présente invention concerne l'utilisation de ces composés pour prévenir et/ou traiter des troubles et/ou des maladies associés à des réactions inflammatoires. L'invention concerne également une composition pharmaceutique et alimentaire contenant ces composés.